FDA’s Technology Plan Will Wound, But Not Kill, Paper Submissions By 2012
Executive Summary
FDA is seeking comment on the next steps the agency plans to take under the fourth extension of the Prescription Drug User Fee Act in order to move towards its vision of eliminating paper for the submission and review of all regulatory documents
You may also be interested in...
PDUFA IV Technology Plan Aspects Needs Prioritization, Commenters Say
FDA needs to prioritize the actions it is proposing under a draft of the PDUFA IV Information Technology Plan, according to comments received from the pharmaceutical industry on the draft
PDUFA IV Technology Plan Aspects Needs Prioritization, Commenters Say
FDA needs to prioritize the actions it is proposing under a draft of the PDUFA IV Information Technology Plan, according to comments received from the pharmaceutical industry on the draft
Electronic NDA Requirement Should Be Phased In Over 3 Years, Small Firms Say
Small pharmaceutical companies favor FDA's proposal to move from paper to electronic filing of regulatory submissions but want a three-year grace period following the agency's issuance of a final rule